The use of phantoms in radiooncology becomes more and more important. Especially the increasing demand on accuracy in radiotherapy leads to further requirements for quality assurance devices. Not even rigid body phantoms but also anthropomorphic phantoms with realistic soft tissue organs are requested. To imitate organ movements these soft tissue parts should be movable reproducible on realistic paths. New techniques in Medical Engineering can help to get from ideas to practical solutions. Especially 3d-scanning and 3d-printing allow technically feasible devices that can help to increase quality assurance. At DKFZ we have 2 different 3d scanners for varying applications with high resolution to generate 3d models of organs and all kinds of parts. In addition 3 different 3d printers are available to create 3d parts. Various materials such as resin, ABS, PLA and PVA and also flexible material with different Shore hardnesses can be used to build challenging parts. These parts can on the one hand be used directly in anthropomorphic phantoms and on the other hand also as casting mould to fabricate flexible organs by using silicone materials. The first talk of the focus session "Development and use of anthropomorphic phantoms in radiooncology" shows a brief overview about the technical possibilities to realize scientific ideas with 3d scanning and printing devices.
To investigate the uncertainties introduced by motion in radiation therapy, anthropomorphic phantoms are needed. They allow for the simulation of the movements of organs during a course of radiation therapy in a reproducible way and the measurement of the radiation doses. Therefore, we use DICOM-data of patients from which segmentations of the bones and organs are exported in the .stl-format and further processed. This is done with the software "Geomagic Freeform" or "Autodesk Inventor", to develop a virtual model. In this process, modifications like underparts, cavities, connecting elements or casts for molds are designed. Different 3D printing techniques are exploited for the production of bone models and molds. In diverse casting processes using several different silicons, the organ models are produced. Different requirements as well as properties in the CT or MR imaging determine the choice of the silicon type. The requirements relate to the extensibility, the stabilization or the connection between the organ models and the placement of dosimeters like OSLDs or dosimetry films. Particular attention is paid to the fact that the anatomical conditions are used in a functional way. Using the contrast between different silicon types, localizers in the form of silicon dots can be integrated in the organ shells and allow for the validation of registration-tools. In radiotherapy the requirements for phantoms used for "End-to-End"-measurements have in-creased sharply over the last few years. Mainly rigid phantoms, consisting of materials with differ-ent densities, in which movements of tumours can be simulated by mechanical displacements, were used in the past. In contrast specific gels allow an optimization of movable models. Due to their composition gels show different elasticity and different signals in MRI and CT by adding soluble salts. Furthermore physiological systems, such as filling the bladder or rectum and ventilating a syn-thetic lung, can be placed inside of the phantom. Dosimetry gels have become very important for the development of anthropomorphic phantoms. Because of its three dimensional representation of dose distribution, different experiments can be evaluated by MRI without any further processing. It is also possible to use modified gels for Proton-therapy. In the process oxygen 18 causes a nuclear reaction, which synthesizes the beta emitter fluorine 18. This final product is used as a contrast me-dium in PETimaging. In summary it is clear that using different kind of gels open up a new spec-trum in radio-oncology. They close a gap in the development and production of anthropomorphic phantoms using 3D-printing and elastomers. Due to the invention of hybrid imaging devices such as MR/PET, PET/CT and MR/LINAC all of these above-mentioned systems complement the con-struction of versatile phantoms.
With magnetic resonance imaging (MRI) becoming an important part of the treatment process -not least recently in MR-guided radiotherapy -established phantoms (e.g. the Alderson head) were no longer sufficient for so called "end-to-end" tests. Such tests covering every step from therapy planning to follow-up are required for quality assurance in radiotherapy. To meet this demand, a first anthropomorphic multimodality head phantom prototype was developed at the German Cancer Research Center (DKFZ) four years ago. A set of patient computed tomography (CT) images was used as the basis for the anthropomorphic head shape. The phantom recipient consisting of epoxy resin was produced using the, at that time, advancing technique of 3D printing. The recipient was filled with a cranial bone surrogate (based on dipotassium phosphate), a brain surrogate (based on agarose gel) and a surrogate for cerebrospinal fluid (based on distilled water). A tumour volume was realized using normoxic dosimetric gel. In addition, the recipient included a nasal air cavity. The entire workflow of a proton therapy treatment was successfully applied to the phantom. CT measurements revealed CT numbers agreeing with reference values for all surrogates. MRI showed the desired contrasts between different phantom materials especially in T2-weighted images (except for the bone surrogate). T2-weighted readout of the dosimetric gel allowed approximate proton range verification. Fusing 3D printing with the usage of gels and designing phantoms based on patient imaging data enabled the development of an anthropomorphic multimodality head phantom prototype that successfully underwent every step in proton therapy treatment.
In radiotherapy the use of (measuring) phantoms is essential. Their main field of application is quality assurance. Simulations and measurements are performed in the phantom and the results are transmitted to humans. With continual developed state of the art and the more complex treatment techniques the complexity of standards on function and property of phantoms are also increasing. An anthropomorphic, deformable and multimodal pelvic phantom (ADAM Pelvic Phantom) has been developed for use in radiooncology. It is an in-house development and implementation at most real setup of tissue, organs and bones for simulating a human pelvis. The phantom allows a patient similar use in imaging and therapy. It allows controlled organ movements and provides the advantages of known materials and geometries. A number of CT scans were performed at the CT Dual Source (Siemens) for this phantom. The filling of the rectum, the bladder and the rotation of the whole phantom varied. With the aid of these datasets, the process of an adaptive planning from the elastic registration via the dose tracking to the adaptive replanning using the treatment planning system RayStation (RaySearch) was investigated. Due to the changed organ position and organ size as well as positioning of the phantom, local dose differences in the organs at risk and the target volume were achieved. However, the overall dose of the organs at risk and the target volume remained the same on average. These local dose differences could be avoided by adaptive replanning.
